Literature DB >> 2001288

Endothelial and epithelial cell adhesion molecules.

S M Albelda1.   

Abstract

This review will discuss a number of specific cell adhesion molecules present on the surface of endothelial and epithelial cells in the lung. Molecules such as integrins, proteoglycans, and the hyaluronic acid receptor, CD44, are found on the abluminal or basement membrane side of the cell and function as cell-substratum receptors. Cadherins, integrins, and platelet-endothelial cell adhesion molecule-1 (PECAM-1) are present at the cell-cell borders of adjacent endothelial and/or epithelial cells and function to initiate or maintain cell-cell adhesion. Finally, a number of inducible cell adhesion molecules such as endothelial-leukocyte adhesion molecule-1 (ELAM-1), granule-associated membrane protein 140 (GMP140), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) are expressed on the luminal surfaces of these cells during inflammation and function as cell-cell adhesion molecules important in white blood cell, platelet, or tumor cell adhesion. These adhesion molecules likely play important roles in maintaining the normal structure and function of the lung, as well as participating in pulmonary processes such as inflammation, wound healing, and the development and spread of malignant disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001288     DOI: 10.1165/ajrcmb/4.3.195

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  73 in total

1.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

Review 2.  Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways.

Authors:  A R Leff
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 3.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

4.  ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis.

Authors:  J Xiao; M Garcia-Lloret; B Winkler-Lowen; R Miller; K Simpson; L J Guilbert
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 5.  Recent advances in asthma.

Authors:  P J Barnes; T H Lee
Journal:  Postgrad Med J       Date:  1992-12       Impact factor: 2.401

Review 6.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

7.  Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.

Authors:  Makan Khoshnejad; Vladimir V Shuvaev; Katherine W Pulsipher; Chuanyun Dai; Elizabeth D Hood; Evguenia Arguiri; Melpo Christofidou-Solomidou; Ivan J Dmochowski; Colin F Greineder; Vladimir R Muzykantov
Journal:  Bioconjug Chem       Date:  2016-01-15       Impact factor: 4.774

8.  Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells.

Authors:  S Klein; F G Giancotti; M Presta; S M Albelda; C A Buck; D B Rifkin
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

9.  Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy.

Authors:  A E Heufelder; R S Bahn
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

Review 10.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.